Corcept Therapeutics Incorporated
Hedge Funds Holdings
Last updated:
Corcept Therapeutics Incorporated‘s stocks are currently a part of 210 hedge funds’ portfolios, which represents 63.91% of the total amount of its stocks outstanding. This makes up a total of 80.50M shares of Corcept Therapeutics Incorporated. Compared to the previous quarter, the number fell by -0.08% or -62.13K shares fewer. As for the holding position changes, 31.9% (67) of current hedge fund investors increased the number of shares held, 37.62% (79) of current holders sold a part of the shares held, and 10% (21) closed the holdings completely. 36 hedge funds are new holders of Corcept Therapeutics Incorporated stock in Q1 2022, it is 17.14% of total holders.
Hedge funds holding Corcept Therapeutics Incorporated (Q2 2017 – Q1 2022)
| Q2 2017 | 156 |
|---|---|
| Q3 2017 | 188 |
| Q4 2017 | 186 |
| Q1 2018 | 209 |
| Q2 2018 | 212 |
| Q3 2018 | 204 |
| Q4 2018 | 220 |
| Q1 2019 | 205 |
| Q2 2019 | 181 |
| Q3 2019 | 192 |
| Q4 2019 | 202 |
| Q1 2020 | 200 |
| Q2 2020 | 218 |
| Q3 2020 | 218 |
| Q4 2020 | 219 |
| Q1 2021 | 206 |
| Q2 2021 | 194 |
| Q3 2021 | 195 |
| Q4 2021 | 201 |
| Q1 2022 | 210 |
Hedge funds changes in Corcept Therapeutics Incorporated positions (Q2 2017 – Q1 2022)
| Q2 2017 | 34 | 67 | 39 | 13 | 3 |
|---|---|---|---|---|---|
| Q3 2017 | 47 | 65 | 46 | 12 | 18 |
| Q4 2017 | 40 | 76 | 48 | 43 | -21 |
| Q1 2018 | 56 | 64 | 67 | 29 | -7 |
| Q2 2018 | 26 | 78 | 74 | 22 | 12 |
| Q3 2018 | 25 | 88 | 63 | 32 | -4 |
| Q4 2018 | 41 | 79 | 69 | 25 | 6 |
| Q1 2019 | 28 | 59 | 76 | 41 | 1 |
| Q2 2019 | 17 | 65 | 63 | 36 | 0 |
| Q3 2019 | 29 | 66 | 62 | 18 | 17 |
| Q4 2019 | 35 | 69 | 65 | 24 | 9 |
| Q1 2020 | 36 | 72 | 58 | 35 | -1 |
| Q2 2020 | 44 | 73 | 65 | 26 | 10 |
| Q3 2020 | 31 | 71 | 83 | 30 | 3 |
| Q4 2020 | 34 | 60 | 93 | 32 | 0 |
| Q1 2021 | 24 | 61 | 89 | 34 | -2 |
| Q2 2021 | 16 | 68 | 75 | 27 | 8 |
| Q3 2021 | 24 | 60 | 76 | 21 | 14 |
| Q4 2021 | 29 | 63 | 85 | 25 | -1 |
| Q1 2022 | 36 | 67 | 79 | 21 | 7 |
Hedge funds changes in Corcept Therapeutics Incorporated stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 2,544,000 | 676,000 |
|---|---|---|
| Q3 2017 | 26,011,718,000 | 4,919,000 |
| Q4 2017 | 11,461,000 | 8,913,000 |
| Q1 2018 | 10,846,000 | 9,824,000 |
| Q2 2018 | 8,131,000 | 24,976,000 |
| Q3 2018 | 6,349,000 | 11,814,000 |
| Q4 2018 | 6,782,000 | 10,886,000 |
| Q1 2019 | 4,997,000 | 8,239,000 |
| Q2 2019 | 5,209,000 | 3,269,000 |
| Q3 2019 | 4,414,000 | 4,151,000 |
| Q4 2019 | 10,152,000 | 5,980,000 |
| Q1 2020 | 6,793,000 | 3,441,000 |
| Q2 2020 | 12,393,000 | 10,839,000 |
| Q3 2020 | 25,121,000 | 20,079,000 |
| Q4 2020 | 23,930,000 | 22,925,000 |
| Q1 2021 | 12,542,000 | 11,396,000 |
| Q2 2021 | 11,667,000 | 8,592,000 |
| Q3 2021 | 4,203,000 | 6,777,000 |
| Q4 2021 | 56,995,000 | 45,704,000 |
| Q1 2022 | 10,647,000 | 7,431,000 |